EchoStar Corp. Message Board
-
26,000 offered at .70. chance of a lifetime???
-
I stand corrected. I also didn't realize they got royalties on anything Genzyme produced (re your
"...and will receive royalties in the event of commercial sales of products containing AAV vectors covered by the acquired intellectual property. GO GENZME! -
...and buy Goya.
Sentiment: Strong Buy
-
I believe you are incorrect. AAV was sold to Genzyme, and everything arising from it except Mydicar and Glybera--and of course all Core Phage. But it should be enough. Cheers.
-
standard operating pipe procedure. means nothing.
-
I'd take 12 to 15.
- Reply to
Biometric Enabled Mobile Devices Used for Debit Authentication will Render ATM Heists Impossible
by carp_slayer •May 17, 2013 3:19 PMI don't know what you are talking about--although I appreciate everything you say. Of course standardized adoption by the entire financial industry would have to happen to make it work, But if IWS can provide the software to stop cyber fraud, when cybe fraud occurs, they should say, "If the industry adopted our software, this couldn't happen." And suggest some of the fused offerings which would end the problem.
-
...because I suggest the only analyst who follows the stock comment
on the #$%$ in the quarterly report? What a world! - Reply to
Biometric Enabled Mobile Devices Used for Debit Authentication will Render ATM Heists Impossible
by carp_slayer •May 17, 2013 3:19 PMSo why didn't Miller have a press release saying they could stop it a frigging week ago!!!
-
Would be interesting to hear his opinion on 10Q content.
-
What would it take them to do an inhouse deal with Starbucks? An hour...45 minutes? Add 20% to the bottom line...or more.
-
This is regarding RSV vaccine GV2311: "To be clear however there is no current plan or the resources to advance the program into the clinic without a partner."
eighty patients @ $25k a patient is $2,000,000 for a phase 1. What am I missing? -
Talking about Google on CNBC and mentioned "facial recognition" a few minutes ago. Any ideas what they were getting at?
-
They mention disolving the company TWICE before they mention it under risks. Can you imagine the law suits if they work something out from the price before the Q was released?
-
blodi_yanki,
good, logical, stuff, buy why is she saying in a quarterly report that she can't find a buyer/partner
for breakthrough technology? -
How can you have cures for Herpes and RSV and not find partners?
-
The only negative: why has someone as smart as John Gruber been a huge seller?
Sentiment: Strong Buy
- Reply to
sell all GenVec, Inc allin SCHSQ May020 you will be rich!!!!!! They midify from C11 to C13....... Call them they will tell you
by strongbuy33 •May 14, 2013 10:39 AMWhat does "midify" mean?
-
God help us if they decide to sell (change in portfolio managers; lousy small cap market in general)
-
Quarter after quarter, Swirsky and Fischer (sp?) told us balance and hearing alone would be $200 million to GenVec in royalties, once approved and selling. Why don't they put everything else on hold and wait for Nov and atonal to begin paying off?